Programmable bionanomaterials for revolutionizing cancer immunotherapy
Biomaterials Science · 2024 · 12 (21) · 5415-5432
DOI: 10.1039/d4bm00815d ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2024. Verfasst von Ayushi Sharma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, Uttar Pradesh-281406, India. dhiraj.bhatia@iitgn.…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Cancer Vaccines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 180 Literaturangaben. Gefördert von: Science and Engineering Research Board, Ministry of Earth Sciences.
Abstract (Originalsprache)
Cancer immunotherapy involves a cutting-edge method that utilizes the immune system to detect and eliminate cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, Uttar Pradesh-281406, India. dhiraj.bhatia@iitgn.ac.in.
- Department of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Palaj 382355, Gandhinagar, India.
Förderung
- Science and Engineering Research Board
- Ministry of Earth Sciences
Zitieren
APA
Sharma, A., & Bhatia, D. (2024). Programmable bionanomaterials for revolutionizing cancer immunotherapy. Biomaterials Science, 12(21), 5415-5432. https://doi.org/10.1039/d4bm00815d
Vancouver
Sharma A, Bhatia D. Programmable bionanomaterials for revolutionizing cancer immunotherapy. Biomaterials Science. 2024;12(21):5415-5432. doi:10.1039/d4bm00815d
BibTeX
@article{Sharma2024,
author = {Sharma, Ayushi and Bhatia, Dhiraj},
title = {Programmable bionanomaterials for revolutionizing cancer immunotherapy},
journal = {Biomaterials Science},
year = {2024},
volume = {12},
number = {21},
pages = {5415--5432},
doi = {10.1039/d4bm00815d}
}
EUVIMED